Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market
A minimally invasive treatment termed percutaneous transluminal coronary angioplasty (PTCA), also known as percutaneous coronary intervention (PCI), is used to unblock stenosed or blocked coronary arteries, enabling the free flow of blood to the myocardium. The lipid-rich plaque in the arteries causes obstruction, which reduces blood flow to the myocardium. Atherosclerosis is the term for the buildup of lipid-rich plaque in arteries, and coronary artery disease is the condition that results while atherosclerosis damaging the coronary arteries.
The working concept of a PTCA catheter is hydraulic pressurization, which is provided by an inflated balloon connected to the distal end. The shaft of a PTCA balloon catheter might have one or two lumens. The catheter has a polymer-made balloon with the right level of compliance for clinical use.
Over the projection period, the percutaneous transluminal coronary angioplasty (PTCA) market is anticipated to develop as cardiovascular disease epidemiology increases globally.
To Get More Business Strategies Request Sample Copy of This Research Report:) @ https://www.coherentmarketinsights.com/insight/request-sample/5194
For instance, the Centers for Disease Control and Prevention reported that in 2020, over 20.1 million persons aged 20 and older had cardiovascular illnesses (or 7.2% of the population), and that in the United States, nearly 2 in 10 fatalities from cardiovascular diseases occurred among those under 65.
The market for PTCA (percutaneous transluminal coronary angioplasty) balloon catheters is anticipated to reach US$ 2.2 billion in 2022 and grow at a CAGR of 8% during the forecast period (2022–2030)
Over the course of the forecast period, the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is anticipated to increase as a result of rising product launches and approvals.
For instance, two high-performance balloons for vessel results obtained ORIGIN NC was introduced by MedAlliance, medical technology business with its headquarters in Switzerland, in July 2021. A semi-compliant (SC) PTCA with a very low crossing profile is called ORIGIN SC. It has balloon diameters of 1.00 mm, 1.25 mm, 1.50 mm, and 1.75 mm to treat extremely tiny vessels and difficult patients.
A non-compliant (NC) PTCA balloon called ORIGIN NC combines high-pressure tolerance, regulated compliance, and an ideal crossing profile for difficult patients.
Additionally, a manufacturer of medical products called S3V Vascular Technologies Private Limited introduced Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters in August 2018.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/5194
Impact of Coronavirus
On December 31, 2019, Wuhan, China, received the first report of the coronavirus (COVID-19) epidemic. On March 11, 2020, the World Health Organization classified COVID-19 as a pandemic. Over 583,038,110 cases of coronavirus illness (COVID-19) were recorded through August 9, 2022, according to the World Health Organization’s Coronavirus (COVID-19) Weekly Epidemiological Update.
Since patients undergoing heart surgery are more likely to experience COVID-19 problems and demand limited resources like intensive care beds, the number of cardiac patients admitted during the height of the COVID-19 outbreak was decreased. Additionally, only dire situations were attended to, such acute aortic dissections.
Furthermore, according to a CTV News piece from September 2021, Hamilton General Hospital was forced to postpone all cardiac operations for a full day in order to make room for COVID-19 patients in its intensive care unit.
Market Restraint
Over the projected period, rising product recalls are anticipated to restrain the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market‘s expansion. For instance, in February 2020, the medical device and healthcare company Abbott voluntarily recalled specific lots of its NC Trek RX Coronary Dilatation Catheter and NC Traveler Coronary Dilatation Catheter coronary angioplasty catheters because the balloons from the lots in question might not deflect as intended. This recall was categorised as a Class I recall by the US Food and Drug Administration.
Key Players
S3V Vascular, Cook Group, Nordson Corporation, Microport Scientific Corporation, Medtronic Plc., Shockwave Medical Inc., Becton, Biomerics, Dickinson and Company, BIOTRONIK SE & Co. KG, Abbott, Teleflex Incorporated, Koninklijke Philips N.V., Surmodics, Inc., ENDOCOR GmbH, Boston Scientific Corporation, Cardinal Health, NIPRO, and Terumo Corporation are significant players in the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market.
Grab the Offer and Get UpTo 30% Discount on This Research Report 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/5194
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Balloon Material
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Mergers & Acquisitions
- Market Dynamics
- Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials
- Government Initiatives
- Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Normal Balloon Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Drug Eluting Balloon Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Cutting Balloon Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Scoring Balloon Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Balloon Material, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Polyolefin copolymer (POC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Polyethylene (PE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Polyethylene terephthalate (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By End User, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/percutaneous-transluminal-coronary-angioplasty-balloon-catheter-market-4484
𝗔𝗯𝗼𝘂𝘁 𝗨𝗦:
Coherent Market Insights is a company that offers consultancy services, syndicated research studies, and custom research papers for the global market. In a wide range of industries, including aerospace and defence, agriculture, food and beverage, automotive, chemicals and materials, and practically every other industry imaginable, we are renowned for our actionable insights and reliable reports. Our extremely trustworthy and precise reports add value for clients. In addition, we are committed to continuing to provide our clients with quantifiable, long-lasting outcomes by taking the lead in providing insights in numerous areas after COVID-19.
𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837